Literature DB >> 30156713

Stakeholders analysis of merging social health insurance funds in Iran: what kind of interests they may gain or lose?

Mohammad Bazyar1, Arash Rashidian2, Minoo Alipouri Sakha2, Leila Doshmangir3,4, Nouroddin Rahimi5, Mohammad Ranjbar6, Seyyedeh Fatemeh Sagha Abolfazl7, Seyed Moussa Tabatabaei Lotfi7, Alireza Olyaeemanesh7,8.   

Abstract

Iran passed a Law in 2010 to merge all existing health insurance funds physically together. This stakeholder analysis aimed at revealing that what benefits the stakeholders might lose or gain as a result of merging health insurance schemes in Iran, which make them to oppose or support it. This was a qualitative study conducted in 2014. Sixty semi-structured face-to-face interviews were conducted. Purposive and snowball samplings with maximum heterogeneity samples were used for selecting interviewees. Government is not willing to undertake more financial commitment. Existing health insurance schemes like Social Security Organization and minor well-resourced health insurance funds and also worker unions are unwilling to lose their financial and organizational autonomy, to share their benefits with other less privileged groups, or face likely financial challenges in running their health facilities like hospitals. Top managers and workforces are worried to lose their job, salary, or organizational positions. Ministry of Cooperation, Labour, and Social Welfare does not want to lose its control on health insurance schemes. Ministry of Health and Medical Education and Iran Health Insurance Organization are among actors that support the insurance funds merging policy. Successful implementing of consolidation requires taking into account the interests of different stakeholders.
© 2018 John Wiley & Sons, Ltd.

Keywords:  Iran; conflict of interest; health insurance; merger; stakeholder analysis

Mesh:

Year:  2018        PMID: 30156713     DOI: 10.1002/hpm.2605

Source DB:  PubMed          Journal:  Int J Health Plann Manage        ISSN: 0749-6753


  5 in total

1.  Future Development Through the Past: Pathology of the Financing Dimension of Iran's Health Transformation Plan.

Authors:  Leila Doshmangir; Behzad Najafi; Hakimeh Mostafavi; Esmaeil Moshiri
Journal:  Clinicoecon Outcomes Res       Date:  2020-07-07

2.  Combining health insurance funds in a fragmented context: what kind of challenges should be considered?

Authors:  Mohammad Bazyar; Arash Rashidian; Minoo Alipouri Sakha; Mohammad Reza Vaez Mahdavi; Leila Doshmangir
Journal:  BMC Health Serv Res       Date:  2020-01-08       Impact factor: 2.655

Review 3.  Iran health insurance system in transition: equity concerns and steps to achieve universal health coverage.

Authors:  Leila Doshmangir; Mohammad Bazyar; Arash Rashidian; Vladimir Sergeevich Gordeev
Journal:  Int J Equity Health       Date:  2021-01-14

4.  What are the potential advantages and disadvantages of merging health insurance funds? A qualitative policy analysis from Iran.

Authors:  Mohammad Bazyar; Vahid Yazdi-Feyzabadi; Nouroddin Rahimi; Arash Rashidian
Journal:  BMC Public Health       Date:  2020-08-31       Impact factor: 3.295

5.  Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis.

Authors:  Alireza Olyaaeemanesh; Ebrahim Jaafaripooyan; Akbar Abdollahiasl; Majid Davari; Seyyed Meysam Mousavi; Mansoor Delpasand
Journal:  Health Res Policy Syst       Date:  2021-12-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.